Page 51 - Read Online
P. 51

Page 8 of 11         Cote et al. J Cancer Metastasis Treat 2022;8:36  https://dx.doi.org/10.20517/2394-4722.2022.41

               dynamics; therefore, further evaluating these strategies is warranted for the treatment of MM.


               DECLARATIONS
               Authors’ contributions
               Wrote and edited the manuscript: Cote A, Messier T, Cunniff B


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               Brian Cunniff receives funding from RS Oncology, LLC through a Sponsored Research Agreement between
               the University of Vermont and RS Oncology, LLC.


               Conflicts of interest
               Brian Cunniff and Terri Messier are paid consultants for RS Oncology, LLC. Brian Cunniff is an equity
               holder in RS Oncology, LLC.


               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2022.


               REFERENCES
               1.       Janes SM, Alrifai D, Fennell DA. Perspectives on the treatment of malignant pleural mesothelioma. N Engl J Med 2021;385:1207-18.
                    DOI  PubMed
               2.       Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell 2012;48:158-67.  DOI  PubMed  PMC
               3.       Urso L, Cavallari I, Sharova E, Ciccarese F, Pasello G, Ciminale V. Metabolic rewiring and redox alterations in malignant pleural
                    mesothelioma. Br J Cancer 2020;122:52-61.  DOI  PubMed  PMC
               4.       Kleih M, Böpple K, Dong M, et al. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of
                    ovarian cancer cells. Cell Death Dis 2019;10:851.  DOI  PubMed  PMC
               5.       Cunniff B, Newick K, Nelson KJ, et al. Disabling mitochondrial peroxide metabolism via combinatorial targeting of peroxiredoxin 3
                    as an effective therapeutic approach for malignant mesothelioma. PLoS One 2015;10:e0127310.  DOI  PubMed  PMC
               6.       Nelson KJ, Messier T, Milczarek S, et al. Unique cellular and biochemical features of human mitochondrial peroxiredoxin 3 establish
                    the molecular basis for its specific reaction with thiostrepton. Antioxidants (Basel) 2021;10:150.  DOI  PubMed  PMC
               7.       Reczek CR, Chandel NS. ROS-dependent signal transduction. Curr Opin Cell Biol 2015;33:8-13.  DOI  PubMed  PMC
               8.       Finkel T. Signal transduction by reactive oxygen species. J Cell Biol 2011;194:7-15.  DOI  PubMed  PMC
               9.       Ježek P, Holendová B, Plecitá-Hlavatá L. Redox Signaling from mitochondria: signal propagation and its targets. Biomolecules
                    2020;10:93.  DOI  PubMed  PMC
               10.       Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes.
                    Trends Biochem Sci 2010;35:505-13.  DOI  PubMed  PMC
               11.       Enyedi B, Zana M, Donkó Á, Geiszt M. Spatial and temporal analysis of NADPH oxidase-generated hydrogen peroxide signals by
                    novel fluorescent reporter proteins. Antioxid Redox Signal 2013;19:523-34.  DOI  PubMed
               12.       Dröse S. Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre- and
                    postconditioning. Biochim Biophys Acta 2013;1827:578-87.  DOI  PubMed
               13.       Marzo N, Chisci E, Giovannoni R. The Role of hydrogen peroxide in redox-dependent signaling: homeostatic and pathological
                    responses in mammalian cells. Cells 2018;7:156.  DOI  PubMed  PMC
               14.       Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008;30:393-
                    402.  DOI  PubMed
               15.       Chandel NS, McClintock DS, Feliciano CE, et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-
   46   47   48   49   50   51   52   53   54   55   56